Abstract:ObjectiveTo analyze the therapeutic effect of fluticasone propionate nasal spray for upper airway cough syndrome(UACS) in children.Methods121 pediatric patients with UACS were randomly divided into two groups, i.e. therapeutic group (n=63) and control group (n=58). The primary diseases in both groups were treated with homologous therapeutic measures. The patients of therapeutic group were given fluticasone propionate while those of the control group were given nose drop of nitrofural and ephedrine hydrochloride. After continuous treatment for 4 weeks, visual analog scale (VAS) was adopted to evaluate the improvement of cough.ResultsAll patients were followed up for 4 weeks, the symptoms including chronic cough, postnasal drip got relieved to different degree in all cases. The effective rate of therapeutic group was higher than that of the control group, and the difference was statistically significant (P<0.05).ConclusionsIntranasal corticosteroid is safe and effective for the treatment of UACS in pediatric patients.